Entrapment of rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-guanine nucleotide dissociation inhibitor-1 complex

被引:76
作者
Genth, H
Gerhard, R
Maeda, A
Amano, M
Kaibuchi, K
Aktories, K
Just, I
机构
[1] Hannover Med Sch, Inst Toxikol, D-30625 Hannover, Germany
[2] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79098 Freiburg, Germany
[3] Nagoya Univ, Dept Cell Pharmacol, Grad Sch Med, Nagoya, Aichi 4668550, Japan
关键词
D O I
10.1074/jbc.M301915200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RhoA, -B, and -C are ADP-ribosylated by Clostridium botulinum exoenzyme C3 to induce redistribution of the actin filaments in intact cells, a finding that has led to the notion that the ADP-ribosylation blocks coupling of Rho to the downstream effectors. ADP-ribosylation, however, does not alter nucleotide binding, intrinsic, and GTPase-activating protein-stimulated GTPase activity. ADP-ribosylated Rho is even capable of activating the effector protein ROK in a recombinant system. Treatment of cells with a cell-permeable chimeric C3 toxin led to complete localization of modified Rho to the cytosolic fraction based on the complexation of ADP-ribosylated Rho with the guanine-nucleotide dissociation inhibitor-1 (GDI-1). The modified complex turned out to be resistant to phosphatidylinositol 4,5-bisphosphateand GTPgammaS-induced release of Rho from GDI-1. Thus, ADP-ribosylation leads to entrapment of Rho in the GDI-1 complex. The increased stability of the GDI complex prevented binding of Rho to membrane-associated players of the GTPase cycle such as the activating guanine nucleotide exchange factors and effector proteins.
引用
收藏
页码:28523 / 28527
页数:5
相关论文
共 51 条
[31]   Rho GTPases [J].
Mackay, DJG ;
Hall, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :20685-20688
[32]   Evidence for Rho-mediated agonist stimulation of phospholipase D in Rat1 fibroblasts - Effects of Clostridium botulinum C3 exoenzyme [J].
Malcolm, KC ;
Elliott, CM ;
Exton, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :13135-13139
[33]  
NOBES CD, 1997, BACTERIAL TOXINS TOO, P71
[34]   ACTIVATION OF BOTULINUM C-2 TOXIN BY TRYPSIN [J].
OHISHI, I .
INFECTION AND IMMUNITY, 1987, 55 (06) :1461-1465
[35]   MICROINJECTION OF RECOMBINANT-P21RHO INDUCES RAPID CHANGES IN CELL MORPHOLOGY [J].
PATERSON, HF ;
SELF, AJ ;
GARRETT, MD ;
JUST, I ;
AKTORIES, K ;
HALL, A .
JOURNAL OF CELL BIOLOGY, 1990, 111 (03) :1001-1007
[36]  
REGAZZI R, 1992, J BIOL CHEM, V267, P17512
[37]   Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the Rho-binding domain [J].
Reid, T ;
Furayashiki, T ;
Ishizaki, T ;
Watanabe, G ;
Watanabe, N ;
Fujisawa, K ;
Morii, N ;
Madaule, P ;
Narumiya, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (23) :13556-13560
[38]   Physical association of the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in Swiss 3T3 cells [J].
Ren, XD ;
Bokoch, GM ;
TraynorKaplan, A ;
Jenkins, GH ;
Anderson, RA ;
Schwartz, MA .
MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (03) :435-442
[39]  
SASAKI T, 1993, J BIOL CHEM, V268, P23959
[40]   The Rho small G protein family Rho GDI system as a temporal and spatial determinant for cytoskeletal control [J].
Sasaki, T ;
Takai, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 245 (03) :641-645